INSP
Inspire Medical Systems, Inc.NYSEHealthcareAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
10.89
PEG
0.06
P/B
2.01
P/S
1.71
EV/EBITDA
21.72
DCF Value
$136.96
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.4%
Operating Margin
5.6%
Net Margin
15.9%
ROE
21.1%
ROA
15.8%
ROIC
6.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $269.1M | $136.1M | $4.66 |
| FY 2025 | $912.0M | $145.4M | $4.89 |
| Q3 2025 | $224.5M | $9.9M | $0.34 |
| Q2 2025 | $217.1M | $-3.6M | $-0.12 |
Analyst Ratings
View AllTrading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NYSE
Beta
0.86
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.